ClinicalTrials.gg
CompletedNCT00150384CAPABLEUpdated Jan 27, 2021

Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient Population

A Phase 4 interventional study of Amlodipine/Atorvastatin in Hypertension and Dyslipidemia, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc.. Completed at 106 sites in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-01-27.

Sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (part of Viatris Inc.) · Phase 4, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
500
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 187 studies testing amlodipine in Hypertension — 6 open to participants now, 8 under way, 2 of them phase 3. Amlodipine · Hypertension.

Enrollment
44th of 186
500 · median 180
Started
2004
with 13 others
Phase 4
80 of 187
2 open now
Registered
4th of 187
by date
Lead sponsor
6 of 187
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Among the 187 studies testing amlodipine in Hypertension, this one is the 44th largest by enrollment of the 186 interventional ones that give a count, is one of 14 that started in 2004, is one of 80 in phase 4, and was the 4th registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 911 are open to participants now.

Browse Hypertension studies →

Open to participants now

6 of the 187 studies testing amlodipine in Hypertension are open now, in 4 countries. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

About amlodipine

Amlodipine: first FDA approval 1992 (NORVASC), first EMA approval 2007. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 556 Hypertension studies recruiting now, 262 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 137 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 187 studies testing amlodipine in Hypertension, or all of them as a file.
02

Study summary

The purpose is to demonstrate the utility of Caduet (amlodipine/atorvastatin) in the African American population

03

Conditions studied

  • Hypertension
  • Dyslipidemia
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • African American men and women with concurrent hypertension and dyslipidemia that is either treated or untreated
  • Subjects must satisfy the blood pressure and LDL-C inclusion criteria for their respective Cardiovascular Risk group determined at screening

Exclusion criteria

Exclusion Criteria:

  • Subjects currently being treated with concomitant amlodipine and atorvastatin therapy, including Caduet
  • Subjects with blood pressure at goal
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
500 participants

Interventions

06

What researchers measure

Primary outcomes

  1. To evaluate the efficacy of Caduet therapy by assessing the percentage of intent-to-treat subjects achieving both BP and lipid treatment goals (JNC VII and NCEP ATP III)

Secondary outcomes

  1. To assess the percentage of subjects achieving treatment goals(JNC VII and NCEP) stratified by the final BP and lipid therapy doses, respectively, the change from baseline in lipid profile, SBP and DBP

07

Study locations

106 sites
  • Pfizer Investigational Site
    Birmingham, Alabama 35209, United States
  • Pfizer Investigational Site
    Birmingham, Alabama 35211, United States
  • Pfizer Investigational Site
    Huntsville, Alabama 35801, United States
  • Pfizer Investigational Site
    Little Rock, Arkansas 72204, United States
  • Pfizer Investigational Site
    Los Angeles, California 90024, United States
  • Pfizer Investigational Site
    Oakland, California 94609-3425, United States
  • Pfizer Investigational Site
    Pico Rivera, California 90660, United States
  • Pfizer Investigational Site
    Bridgeport, Connecticut 6610, United States
  • Pfizer Investigational Site
    Washington, District of Columbia 20010, United States
  • Pfizer Investigational Site
    Washington, District of Columbia 20037, United States
  • Pfizer Investigational Site
    Aventura, Florida 33180, United States
  • Pfizer Investigational Site
    Gainesville, Florida 32601, United States
  • Pfizer Investigational Site
    Jacksonville, Florida 32204, United States
  • Pfizer Investigational Site
    Orlando, Florida 32806, United States
  • Pfizer Investigational Site
    Pensacola, Florida 32503, United States
  • Pfizer Investigational Site
    Vero Beach, Florida 32960, United States
  • Pfizer Investigational Site
    Athens, Georgia 30606, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30303, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30309, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30310, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30342, United States
  • Pfizer Investigational Site
    Augusta, Georgia 30904, United States
  • Pfizer Investigational Site
    Columbus, Georgia 31901, United States
  • Pfizer Investigational Site
    Columbus, Georgia 31904, United States
  • Pfizer Investigational Site
    Decatur, Georgia 30033, United States
  • Pfizer Investigational Site
    Lincolnton, Georgia 30817, United States
  • Pfizer Investigational Site
    Savannah, Georgia 31406, United States
  • Pfizer Investigational Site
    Chicago, Illinois 60616, United States
  • Pfizer Investigational Site
    Chicago, Illinois 60637-1470, United States
  • Pfizer Investigational Site
    Maywood, Illinois 60153, United States
  • Pfizer Investigational Site
    Merrillville, Indiana 46410, United States
  • Pfizer Investigational Site
    Overland Park, Kansas 66211, United States
  • Pfizer Investigational Site
    Bossier City, Louisiana 71111, United States
  • Pfizer Investigational Site
    New Orleans, Louisiana 70117-4817, United States
  • Pfizer Investigational Site
    New Orleans, Louisiana 70125, United States
  • Pfizer Investigational Site
    Shreveport, Louisiana 71101, United States
  • Pfizer Investigational Site
    Shreveport, Louisiana 71130, United States
  • Pfizer Investigational Site
    Baltimore, Maryland 21201, United States
  • Pfizer Investigational Site
    Baltimore, Maryland 21215, United States
  • Pfizer Investigational Site
    Columbia, Maryland 21045, United States
  • Pfizer Investigational Site
    Randallstown, Maryland 21133, United States
  • Pfizer Investigational Site
    Rockville, Maryland 20850, United States
  • Pfizer Investigational Site
    Westminster, Maryland 21157, United States
  • Pfizer Investigational Site
    Brockton, Massachusetts 02301, United States
  • Pfizer Investigational Site
    Wellesley Hills, Massachusetts 02481-2106, United States
  • Pfizer Investigational Site
    Detroit, Michigan 48201, United States
  • Pfizer Investigational Site
    Detroit, Michigan 48235, United States
  • Pfizer Investigational Site
    Lansing, Michigan 48917, United States
  • Pfizer Investigational Site
    Livonia, Michigan 48152, United States
  • Pfizer Investigational Site
    Jackson, Mississippi 39202, United States
  • Pfizer Investigational Site
    Jackson, Mississippi 39216, United States
  • Pfizer Investigational Site
    Kansas City, Missouri 64112, United States
  • Pfizer Investigational Site
    Kansas City, Missouri 64131, United States
  • Pfizer Investigational Site
    Saint Louis, Missouri 63104, United States
  • Pfizer Investigational Site
    Saint Louis, Missouri 63110, United States
  • Pfizer Investigational Site
    Saint Louis, Missouri 63141, United States
  • Pfizer Investigational Site
    Cherry Hill, New Jersey 08034, United States
  • Pfizer Investigational Site
    East Orange, New Jersey 07018, United States
  • Pfizer Investigational Site
    Elizabeth, New Jersey 07202, United States
  • Pfizer Investigational Site
    Hammonton, New Jersey 08037, United States
  • Pfizer Investigational Site
    South Bound Brook, New Jersey 08880, United States
  • Pfizer Investigational Site
    Voorhees, New Jersey 08043, United States
  • Pfizer Investigational Site
    Woodbury, New Jersey 08096, United States
  • Pfizer Investigational Site
    Brooklyn, New York 11203, United States
  • Pfizer Investigational Site
    Brooklyn, New York, United States
  • Pfizer Investigational Site
    Buffalo, New York 14215, United States
  • Pfizer Investigational Site
    Mineola, New York 11501, United States
  • Pfizer Investigational Site
    Charlotte, North Carolina 28209, United States
  • Pfizer Investigational Site
    Greenville, North Carolina 27834, United States
  • Pfizer Investigational Site
    Monroe, North Carolina 28112, United States
  • Pfizer Investigational Site
    Monroe, North Carolina, United States
  • Pfizer Investigational Site
    Winston-Salem, North Carolina 27103-3315, United States
  • Pfizer Investigational Site
    Winston-Salem, North Carolina 27103, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45219, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45229, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45236, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45246, United States
  • Pfizer Investigational Site
    Dayton, Ohio 45402, United States
  • Pfizer Investigational Site
    Dayton, Ohio 45406, United States
  • Pfizer Investigational Site
    Maumee, Ohio 43537, United States
  • Pfizer Investigational Site
    Perrysburg, Ohio 43551, United States
  • Pfizer Investigational Site
    Bensalem, Pennsylvania 19020, United States
  • Pfizer Investigational Site
    Philadelphia, Pennsylvania 19141, United States
  • Pfizer Investigational Site
    Philadelphia, Pennsylvania 19146, United States
  • Pfizer Investigational Site
    Philadelphia, Pennsylvania 19148, United States
  • Pfizer Investigational Site
    Bamberg, South Carolina 29003, United States
  • Pfizer Investigational Site
    Charleston, South Carolina 29425, United States
  • Pfizer Investigational Site
    Clinton, South Carolina 29325, United States
  • Pfizer Investigational Site
    Mount Pleasant, South Carolina 29464, United States
  • Pfizer Investigational Site
    Simpsonville, South Carolina 29681, United States
  • Pfizer Investigational Site
    Bartlett, Tennessee 38134, United States
  • Pfizer Investigational Site
    Jackson, Tennessee 38305, United States
  • Pfizer Investigational Site
    Beaumont, Texas 77702, United States
  • Pfizer Investigational Site
    Dallas, Texas 75235, United States
  • Pfizer Investigational Site
    Dallas, Texas 75254, United States
  • Pfizer Investigational Site
    Houston, Texas 77024, United States
  • Pfizer Investigational Site
    Houston, Texas 77030, United States
  • Pfizer Investigational Site
    Houston, Texas 77054, United States
  • Pfizer Investigational Site
    Emporia, Virginia 23847, United States
  • Pfizer Investigational Site
    Norfolk, Virginia 23502, United States

Showing the first 100 of 106 sites. Choose a country and city above to see the rest.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2004 and a completion of Aug 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 6, 2005
First posted
Sep 8, 2005
Start
Jul 2004
CompletionActual
Aug 2005
Last update
Jan 27, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00150384
Responsible party
Sponsor
First posted
Sep 8, 2005
Start date
Jul 2004
Completion
Aug 2005
Last update
Jan 27, 2021

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Amlodipine · Atorvastatin

Start the discussion